EYEG AB Corporate Bond ETF

NAS · US · Healthcare · Biotechnology
34.15USD+0.21%Mkt Cap: —P/E: —

The fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers.…

Key Statistics

Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)—
Revenue/Share—
Last Price34.15 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B—
EPS (TTM)—
EPS (Forward)—
52W Range
33.977% of range36.63
52W High36.63 USD
52W Low33.97 USD
Profitability
Gross Margin—
Oper. Margin—
EBITDA Margin—
Profit Margin—
ROE—
ROA—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio—
Quick Ratio—
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield5.12%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float—
Insiders—
Institutions—
Technical
SMA 5034.19 (-0.1%)
SMA 20035.12 (-2.8%)
Beta—
S&P 52W Chg—
Avg Vol (30d)418
Avg Vol (10d)610
Technical Indicators
RSI (14)39.2
MACD-0.1693
MACD Signal-0.1427
MACD Hist.-0.0266
BB Upper34.85 USD
BB Middle34.38 USD
BB Lower33.91 USD
BB Width2.73%
ATR (14)0.1025 USD
Vol Ratio (20d)0.03x